Cargando…
Panax notoginseng saponins inhibits NLRP3 inflammasome-mediated pyroptosis by downregulating lncRNA-ANRIL in cardiorenal syndrome type 4
OBJECTIVE: Cardiorenal syndrome type 4 (CRS4) is a complication of chronic kidney disease. Panax notoginseng saponins (PNS) have been confirmed to be efficient in cardiovascular diseases. Our study aimed to explore the therapeutic role and mechanism of PNS in CRS4. METHODS: CRS4 model rats and hypox...
Autores principales: | Xu, Ying, Cao, Luxi, Zou, Wenli, Yu, Rizhen, Shen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165771/ https://www.ncbi.nlm.nih.gov/pubmed/37158944 http://dx.doi.org/10.1186/s13020-023-00756-2 |
Ejemplares similares
-
Saponin accumulation in the seedling root of Panax notoginseng
por: Wang, Dong, et al.
Publicado: (2011) -
New dammarane-type triterpenoid saponins from Panax notoginseng saponins
por: Li, Qian, et al.
Publicado: (2020) -
Pustular drug eruption due to Panax notoginseng saponins
por: Yin, ZhiQiang, et al.
Publicado: (2014) -
Stereoisomers of Saponins in Panax notoginseng (Sanqi): A Review
por: Peng, Ming, et al.
Publicado: (2018) -
Effect of the combination of astragaloside IV and Panax notoginseng saponins on pyroptosis and necroptosis in rat models of cerebral ischemia-reperfusion
por: Tang, Biao, et al.
Publicado: (2021)